Field Trip Health Expands Bought Deal To $17.4 Million

As has become a trend within the psychedelics space, Field Trip Health (CSE: FTRP) this morning announced an increase to its bought deal private placement that was originally announced last night. The upsizing was expected, given that the equity had remained halted despite the news being released last night. The financing as a whole has now increased from $15.0 million to $17.4 million.

The financing, which is being lead by Stifel whom is lead underwriter and sole bookrunner, will now see 3.9 million units of the company sold at $4.50 per unit, for gross proceeds of $17.4 million. Units are to consist of one common share and one half warrant of the company, with each full warrant having an exercise price of $5.60 per share for a period of 18 months following the closing of the transaction.

An acceleration clause is also present on the warrant, enabling the company to accelerate the expiry of the warrant should common shares of the company exceed a volume weighted average trading price of $9.00 for a period of ten consecutive trading days.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

An over-allotment option has also been granted under the financing, as has become customary of late, with the option enabling the underwriters to expand the financing to a total figure of $20.0 million should it be exercised in full. The option exists for a period of 30 days following the closing of the offering.

Net proceeds from the financing are said to be for working capital and general corporate purposes.

Field Trip Health last traded at $5.00 on the CSE.


Information for this analysis was found via Sedar and Field Trip Health. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Field Trip Health Closes $20.0 Million Bought Deal

Field Trip Health (CSE: FTRP) this morning announced the closing of its bought deal financing,...

Tuesday, January 5, 2021, 10:11:00 AM

Field Trip Health To Launch Amsterdam Location Focused On Psychedelic Truffles

Field Trip Health (CSE: FTRP) is going to Amsterdam. The company announced this morning that...

Tuesday, November 17, 2020, 08:30:37 AM

Field Trip Health To Uplist To TSX Next Week

Field Trip Health (CSE: FTRP) is growing up. The company this morning announced that it...

Thursday, June 3, 2021, 08:08:47 AM

Field Trip Health To Divide Into Two Separate Firms

Field Trip Health (TSX: FTRP) is set to be split into two separate firms. The...

Friday, April 29, 2022, 08:01:36 AM

Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health

In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably...

Sunday, November 1, 2020, 09:00:00 AM